GE HealthCare Stock Gains After Jefferies Analysts Name It ‘Franchise Pick’
:max_bytes(150000):strip_icc()/GettyImages-1480617392-8937a3041ed1421c9bd6445a58231ffe.jpg?w=780&resize=780,470&ssl=1 "GE HealthCare Stock Gains After Jefferies Analysts Name It ‘Franchise Pick’")
Key Takeaways
- GE HealthCare shares gained Wednesday after Jefferies analysts upgraded their rating for the stock to “buy” and raised their price target.
- The analysts said the firm holds a leading position in the diagnostic imaging market, which they expect to grow by mid-single digits.
- Jefferies added improving business in China “could be another icing on the cake.”
GE HealthCare Technologies (GEHC) shares gained Wednesday after Jefferies analysts called the stock a “franchise pick” and made a bullish case for the company’s diagnostic imaging business.
Jefferies bumped its rating for the stock up to “buy” from “hold,” and raised its price target to $103 from $95, bringing it above the broader analyst consensus compiled by Visible Alpha at about $95. Shares rose 3.5% to close at $86.26 Wednesday and have added about 13% over the past year.
The analysts said the firm holds a leading position in the diagnostic imaging market, which they expect to grow by mid-single digits. GE HealthCare could also benefit from market consolidation, they noted.
Jefferies added that improving business in China “could be another icing on the cake.” China makes up 12% of the company’s sales, and GE HealthCare said in October that macroeconomic weakness in the country negatively impacted third-quarter sales.
Source link
